MIMEDX To Highlight Published Data At SAWC Fall
Portfolio Pulse from Benzinga Newsdesk
MiMedx Group, Inc. (NASDAQ:MDXG) announced it will sponsor an Innovation Theater lunch symposium at the Symposium on Advanced Wound Care (SAWC) Fall meeting. The company will also participate in the conference's exhibition. The symposium will review recent data on the clinical and economic impacts of using skin substitutes in the treatment of Venous Leg Ulcers and the impact of adequate debridement in the treatment of chronic wounds. The company's recently launched tri-layer placental allograft, EPIEFFECT®, will also be discussed.
November 02, 2023 | 12:22 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
MiMedx's participation in the SAWC Fall meeting and the discussion of its new product, EPIEFFECT®, could potentially increase its visibility and credibility in the market.
The company's active participation in a major industry event and the discussion of its new product could potentially attract more customers and investors, leading to a positive impact on its stock price.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100